BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22210436)

  • 21. Normalization of the ovarian cancer microenvironment by SPARC.
    Said N; Socha MJ; Olearczyk JJ; Elmarakby AA; Imig JD; Motamed K
    Mol Cancer Res; 2007 Oct; 5(10):1015-30. PubMed ID: 17951402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF).
    Ling MT; Lau TC; Zhou C; Chua CW; Kwok WK; Wang Q; Wang X; Wong YC
    Carcinogenesis; 2005 Oct; 26(10):1668-76. PubMed ID: 15905202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo.
    Ramakrishnan S; Olson TA; Bautch VL; Mohanraj D
    Cancer Res; 1996 Mar; 56(6):1324-30. PubMed ID: 8640821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of laser-induced choroidal neovascularization by atorvastatin by downregulation of monocyte chemotactic protein-1 synthesis in mice.
    Yamada K; Sakurai E; Itaya M; Yamasaki S; Ogura Y
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1839-43. PubMed ID: 17389519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SV40 T/t-common polypeptide inhibits angiogenesis and growth of HER2-overexpressing human ovarian cancer.
    Hsueh SP; Hsu WB; Wen CC; Wang WB
    Cancer Gene Ther; 2011 Dec; 18(12):859-70. PubMed ID: 21869825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model.
    Wiener JR; Nakano K; Kruzelock RP; Bucana CD; Bast RC; Gallick GE
    Clin Cancer Res; 1999 Aug; 5(8):2164-70. PubMed ID: 10473101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
    Huang S; Xie K; Bucana CD; Ullrich SE; Bar-Eli M
    Clin Cancer Res; 1996 Dec; 2(12):1969-79. PubMed ID: 9816156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of tumor induced angiogenesis in Ehrlich ascites tumor.
    Ghosh S; Roy S; Banerjee M; Maity P
    J Exp Clin Cancer Res; 2004 Dec; 23(4):681-90. PubMed ID: 15743040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dab2 is pivotal for endothelial cell migration by mediating VEGF expression in cancer cells.
    Cheong SM; Choi H; Hong BS; Gho YS; Han JK
    Exp Cell Res; 2012 Mar; 318(5):550-7. PubMed ID: 22265793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers.
    Kryczek I; Lange A; Mottram P; Alvarez X; Cheng P; Hogan M; Moons L; Wei S; Zou L; Machelon V; Emilie D; Terrassa M; Lackner A; Curiel TJ; Carmeliet P; Zou W
    Cancer Res; 2005 Jan; 65(2):465-72. PubMed ID: 15695388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutant MCP-1 therapy inhibits tumor angiogenesis and growth of malignant melanoma in mice.
    Koga M; Kai H; Egami K; Murohara T; Ikeda A; Yasuoka S; Egashira K; Matsuishi T; Kai M; Kataoka Y; Kuwano M; Imaizumi T
    Biochem Biophys Res Commun; 2008 Jan; 365(2):279-84. PubMed ID: 17991428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelial growth factor-induced skin carcinogenesis depends on recruitment and alternative activation of macrophages.
    Linde N; Lederle W; Depner S; van Rooijen N; Gutschalk CM; Mueller MM
    J Pathol; 2012 May; 227(1):17-28. PubMed ID: 22262122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic background determines mouse strain differences in inflammatory angiogenesis.
    Marques SM; Campos PP; Castro PR; Cardoso CC; Ferreira MA; Andrade SP
    Microvasc Res; 2011 Nov; 82(3):246-52. PubMed ID: 21907724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis.
    Takahashi Y; Koyanagi T; Suzuki Y; Saga Y; Kanomata N; Moriya T; Suzuki M; Sato Y
    Mol Cancer Res; 2012 Sep; 10(9):1135-46. PubMed ID: 22826464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional characterization of tumor necrosis factor superfamily 15 (TNFSF15) induced by lipopolysaccharides and Eimeria infection.
    Park SS; Lillehoj HS; Hong YH; Lee SH
    Dev Comp Immunol; 2007; 31(9):934-44. PubMed ID: 17349692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis.
    Hajitou A; Sounni NE; Devy L; Grignet-Debrus C; Lewalle JM; Li H; Deroanne CF; Lu H; Colige A; Nusgens BV; Frankenne F; Maron A; Yeh P; Perricaudet M; Chang Y; Soria C; Calberg-Bacq CM; Foidart JM; Noël A
    Cancer Res; 2001 Apr; 61(8):3450-7. PubMed ID: 11309307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VEGF suppresses T-lymphocyte infiltration in the tumor microenvironment through inhibition of NF-κB-induced endothelial activation.
    Huang H; Langenkamp E; Georganaki M; Loskog A; Fuchs PF; Dieterich LC; Kreuger J; Dimberg A
    FASEB J; 2015 Jan; 29(1):227-38. PubMed ID: 25361735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice.
    Robinson-Smith TM; Isaacsohn I; Mercer CA; Zhou M; Van Rooijen N; Husseinzadeh N; McFarland-Mancini MM; Drew AF
    Cancer Res; 2007 Jun; 67(12):5708-16. PubMed ID: 17575137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vector-based RNAi approach to isoform-specific downregulation of vascular endothelial growth factor (VEGF)165 expression in human leukemia cells.
    Shen HL; Xu W; Wu ZY; Zhou LL; Qin RJ; Tang HR
    Leuk Res; 2007 Apr; 31(4):515-21. PubMed ID: 17034851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor necrosis factor superfamily 15 promotes lymphatic metastasis via upregulation of vascular endothelial growth factor-C in a mouse model of lung cancer.
    Qin T; Huang D; Liu Z; Zhang X; Jia Y; Xian CJ; Li K
    Cancer Sci; 2018 Aug; 109(8):2469-2478. PubMed ID: 29890027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.